Endo International plc 4

Accession 0001209191-14-016913

CIK 0001593034operating

View on SEC.gov Company Profile

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 6:48 PM ET

Size

25.0 KB

Accession

0001209191-14-016913

Insider Transaction Report

Form 4

Period: 2014-02-28

Endo International plcENDP

DELUCCA JOHN

Director

Transactions

Award
2007 Stock Incentive Plan Stock Options (NQ)
2014-02-28+8,094→ 8,094 total
Exercise: $23.82Exp: 2020-03-12→ Ordinary Shares (8,094 underlying)
Award
2010 Stock Incentive Plan Restricted Stock Units (RSU)
2014-02-28+6,515→ 6,515 total
Award
2000 Stock Incentive Plan Stock Options (NQ)
2014-02-28+4,567→ 4,567 total
Exercise: $29.84Exp: 2017-03-12→ Ordinary Shares (4,567 underlying)
Award
2007 Stock Incentive Plan Stock Options (NQ)
2014-02-28+6,764→ 6,764 total
Exercise: $24.63Exp: 2018-03-12→ Ordinary Shares (6,764 underlying)
Award
Ordinary shares
2014-02-28+21,596→ 21,596 total
Award
2004 Stock Incentive Plan Stock Options (NQ)
2014-02-28+10,000→ 10,000 total
Exercise: $31.43Exp: 2016-03-13→ Ordinary Shares (10,000 underlying)
Award
2007 Stock Incentive Plan Stock Options (NQ)
2014-02-28+10,384→ 10,384 total
Exercise: $16.80Exp: 2019-03-12→ Ordinary Shares (10,384 underlying)

Footnotes (7)

[F1]On February 28, 2014, Endo Health Solutions, Inc. ("Endo") and Paladin Laboratories Inc. ("Paladin") consummated a transaction under an arrangement agreement pursuant to which each of Endo and Paladin was acquired by a new Irish holding company, Endo International plc ("New Endo"). Under the terms of the arrangement agreement (a) New Endo acquired Paladin pursuant to a plan of arrangement under Canadian law and (b) a newly formed subsidiary of New Endo merged with and into Endo, with Endo as the surviving corporation in the merger (the "Merger") and an indirect wholly owned subsidiary of New Endo. At the effective time of the Merger, each Endo common share was cancelled and converted into the right to receive one New Endo ordinary share. The number here represents shares of New Endo acquired pursuant to the Merger.
[F2]These restricted stock units granted on March 12, 2013 under the 2010 Stock Incentive Plan, which vest 100% on March 12, 2014, were assumed by New Endo in the Merger and converted into New Endo restricted stock units with the same terms and conditions as the original Endo restricted stock units.
[F3]These non-qualified stock options granted on March 13, 2006 under the 2004 Stock Incentive Plan, which were already fully vested as of February 28, 2014, were assumed by New Endo in the Merger and converted into options to purchase ordinary shares of New Endo for the listed exercise price per share with the same terms and conditions as the original Endo stock options.
[F4]These non-qualified stock options granted on March 12, 2007 under the 2000 Stock Incentive Plan, which were already fully vested as of February 28, 2014, were assumed by New Endo in the Merger and converted into options to purchase ordinary shares of New Endo for the listed exercise price per share with the same terms and conditions as the original Endo stock options.
[F5]These non-qualified stock options granted on March 12, 2008 under the 2007 Stock Incentive Plan, which were already fully vested as of February 28, 2014, were assumed by New Endo in the Merger and converted into options to purchase ordinary shares of New Endo for the listed exercise price per share with the same terms and conditions as the original Endo stock options.
[F6]These non-qualified stock options granted on March 12, 2009 under the 2007 Stock Incentive Plan, which were already fully vested as of February 28, 2014, were assumed by New Endo in the Merger and converted into options to purchase ordinary shares of New Endo for the listed exercise price per share with the same terms and conditions as the original Endo stock options.
[F7]These non-qualified stock options granted on March 12, 2010 under the 2007 Stock Incentive Plan, of which 6,071 were already vested as of February 28, 2014 with the unvested portion generally vesting 25% per year on each remaining grant date anniversary through March 12, 2014, were assumed by New Endo in the Merger and converted into options to purchase ordinary shares of New Endo for the listed exercise price per share with the same terms and conditions as the original Endo stock options.

Documents

2 files

Issuer

Endo International plc

CIK 0001593034

→

Entity typeoperating

Related Parties

filerCIK 0001593034

Filing Metadata

Form type: 4
Filed: Mar 3, 7:00 PM ET
Accepted: Mar 4, 6:48 PM ET
Size: 25.0 KB

View on SEC.gov